Exemptia contains Adalimumab, a biologic medicine used to treat autoimmune and inflammatory conditions. It is a monoclonal antibody that specifically targets tumor necrosis factor-alpha (TNF-α), a substance in the body that causes inflammation. Exemptia helps reduce inflammation, swelling, and damage in joints, skin, and other tissues.

Mechanism of action:
Adalimumab binds to TNF-α, preventing it from activating its receptors on cells. TNF-α is a key driver of inflammation in autoimmune diseases. By blocking TNF-α, Exemptia reduces the immune system’s overactive inflammatory response, helping relieve symptoms and prevent tissue damage.

Uses:

• Rheumatoid arthritis

• Psoriatic arthritis

• Ankylosing spondylitis

• Plaque psoriasis

• Crohn’s disease and ulcerative colitis

Adverse effects:
Common side effects include injection site reactions (redness, swelling, pain), headache, rash, and mild infections such as cold or flu. Serious but rare side effects include severe infections (tuberculosis, pneumonia), allergic reactions, liver problems, or rare blood disorders. Patients are usually screened for tuberculosis and hepatitis B before starting treatment.